1. Introduction to Small Drug Molecule
2. Need for Small Molecule Drug
3. Comparison of Cancer Small Molecule Drugs with Other Available Therapies
3.1 Small Molecule Cancer Drugs and its Comparison with Other Drugs Parameters
3.2 Small Molecule Cancer Drug vs. Immunotherapy
3.3 Small Molecule Cancer Drugs vs. Chemotherapy
3.4 Small Molecule Cancer Drug vs. Radiation Therapy
3.5 Small Molecule Cancer Drugs vs. Surgical Removal of Cancer Cells
4. Small Drug Molecule as Emerging Cancer Therapeutics
4.1 Small Molecule Drugs and its Relation with Cancer Treatment
4.2 Mechanisms Targeted by Small Molecule Drugs in Cancer Therapy
4.2.1 Small Molecule Drugs as Growth Factor Kinase Inhibitor for Cancer Therapy
4.2.2 Small Molecule Drugs as DNA Damage Response Inhibitors for Cancer Therapy
4.3 Small Molecule Inhibitors and their Related Pathways
5. Global Trends and Opportunities for Small Molecule Cancer Drug Market
5.1 US
5.2 Europe
5.3 Asia
5.4 Rest of World
6. Global Small Molecule Cancer Drug Clinical Pipeline Overview
6.1 By Phase
6.2 By Formulation
6.3 By Company
6.4 By Country
6.5 By Indication
6.6 By Mechanism of Action
7. Global Analysis for Small Molecule Cancer Drug Research Work at Educational Level
7.1 IACS-10759 Small Molecule Drug Discovery at MD Anderson
7.2 BET Small Molecule Inhibitor Discovery by Yale Researchers for the Cancer
Patients
7.3 Amgen and Mirati’s Small Molecule Cancer Drug against KRAS Gene in Different
Cancer Types
7.4 AOH1160 Small Molecule Research to Focus Breast Cancer at University of
California
8. Global Analysis for Partnerships, Collaborations for Expanding Small Molecule Cancer Drug Market
8.1 IACS and X-Chem to Undergo Small Molecule Cancer Therapies Development
8.2 MD Anderson, Artios Pharma and ShangPharma to Collaborate for Small Molecule
ATR Inhibitor Program
8.3 Aptose Biosciences and Moffitt Cancer Center to Undergo Strategic Collaboration for
the Development of New Multi-Targeting Epigenetic Therapeutic Agents
8.4 Merck and Taiho to Collaborate for Small KRAS- Targeting Cancer Drugs
9. Drivers and Challenges Associated with the Small Molecule Cancer Drug Market
9.1 Potential Insights about Factors Driving the Small Molecule Cancer Drug Market at
Global Level
9.2 Challenges Concerning the Growth of Small Molecule Cancer Drug Market
10. Future Insights for Small Molecule Cancer Market in Cancer Research Area
11. Covid-19 Impact On Small Molecule Cancer Drug Market
12. Small Molecule Drugs for Breast Cancer – Availability, Dosage and Price Analysis
12.1 Ribociclib (Kisqali)
12.2 Alpelisib (Piqray)
12.3 Abemaciclib (Verzenio)
12.4 Talazoparib (Telzenna)
12.5 Nertinib (Nerlynx)
12.6 Palbociclib (Ibrance)
12.7 Ixabepilone (Ixempra)
Anastrazole (Arimidex)
12.8 Lapatinib (Tykerb)
12.9 Toremifene (Fareston)
12.10 Letrozole (Femara)
12.11 Raloxifene (Evista)
12.12 Tamoxifen Oral Liquid (Soltamax)
12.13 Exemestane (Aromasin)
12.14 Testosterone Cypionate (Depo-Testosterone)
12.15 Fluoxymesterone (Halotestine/Androxy)
12.16 Fadrozole (Afema)
12.17 Tamibarotene (Amnolake)
12.18 Testosterone Propionate
13. Small Molecule Drugs for Leukemia Cancer – Availability, Dosage and Price Analysis
13.1 Gilteritinib (Xospata)
13.2 Venetoclax (Venclexta)
13.3 Bosutinib (Bosulif)
13.4 Nilotinib (Tasigna)
13.5 Tretinoin (Vesanoid)
13.6 Clofarabine (Clolar)
13.7 Cytarabine/Daunorubicin (Vyxeos)
13.8 Dasatinib (Sprycel)
13.9 Ponatinib (Iclusig)
13.10 Enasidenib (Idhifa)
13.11 Ivosidenib (Tibsovo)
13.12 Cladribine (Mavenclad/Leustatin)
13.13 Mercaptopurine Oral Suspension (Purixan)
13.14 Methotrexate Oral Solution (Xatmep)
13.15 Pentostatin (Nipent)
13.16 Arsenic Trioxide (Trisenox)
13.17 Quizartinib (Vanflyta)
13.18 Histamine Dihydrochloride Injection (Ceplene)
13.19 Ubenimix (Bestatin)
13.20 Omacetaxine Mepesuccinate (Synribo)
13.21 Radotinib (Supect)
14. Small Molecule Drugs for Lung Cancer – Availability, Dosage and Price Analysis
14.1 Gefitinib (Irresa)
14.2 Entrectinib (Rozlytrek)
14.3 Osimertinib (Tagrisso)
14.4 Erlotinib (Tarceva)
14.5 Brigatinib (Alunbirg)
14.6 Lorbrena (Lorlatinib)
14.7 Vinorelbine (Navelbine)
14.8 Zykadia (Certinib)
14.9 Pemetrexed (Alimta)
14.10 Alectinib (Alecensa)
14.11 Xalkori (Crizotinib)
14.12 Nintedanib (Ofev)
14.13 Anlotinib (Focus V)
14.14 Amrubicin (Calsed)
14.15 Icotinib (Conmana)
15. Small Molecule Drugs for Lymphomas – Availability, Dosage and Price Analysis
15.1 Copanlisib (Aliqopa)
15.2 Methoxsalen Solution (Uvadex)
15.3 Pralatrexate (Folotyn)
15.4 Bexarotene Topical (Targretin Gel)
15.5 Pixantrone (Pixuvri)
15.6 Belinostat (Beleodaq)
15.7 Zanubrutinib (Brukinsa)
15.8 Vorinostat (Zolinza)
15.9 Romidepsin (Istodax)
15.10 Bexarotene (Targretin)
15.11 Mechlorethamine (Valchlor/Ledaga)
16. Small Molecule Drugs for Myeloma – Availability, Dosage and Price Analysis
16.1 Ixazomib (Ninlaro)
16.2 Melphalan Intravenous (Evomela/Chemostat)
16.3 Thalidomide (Thalomid)
16.4 Selinexor (Xpovio)
16.5 Panobinostat (Farydak)
16.6 Bortezomib (Velcade)
16.7 Pomalidomide (Pomalyst)
16.8 Dexamethasone High Dose (Neofordex)
17. Small Molecule Drugs for Prostate Cancer – Availability, Dosage and Price Analysis
17.1 Xtandi (Enzalutamide)
17.2 Apalutamide (Erleada)
17.3 Ertafitinib (Balversa)
17.4 Darolutamide (Nubeqa)
17.5 Bicalutamide (Casodex)
17.6 Nilutamide (Nilandron)
17.7 Abiraterone (Zytiga)
17.8 Xofigo (Radium Ra 223 dichloride)
17.9 Pedeliporfin (Tookad)
18. Small Molecule Drugs for Gastric Cancer – Availability, Dosage and Price Analysis
18.1 Avapritinib (Ayvakit)
18.2 Rivoceranib (Aitan)
18.3 Gimeracil/Oteracil/Tegafur (Teysuno/TS-1)
18.4 Eptaplatin/Heptaplatin
19. Small Molecular Drugs For Cancer Diagnosis – Availability, Dosage and Price Analysis
19.1 Fluciclovine 18F (Axumin)
19.2 Tc 99m Tilmanocept (Lymphoseek)
19.3 Perflubutane (Sonazoid)
19.4 Hexyl Aminolevulinate (Cysview)
19.5 Fluorocholine 18F (IASOcholine/Pcolina)
19.6 Gadobuterol (Gadavist)
20. Small Molecule Drugs for Skin Cancer – Availability, Dosage and Price Analysis
20.1 Benimetinib (Mektovi)
20.2 Cobimetinib (Cotellic)
20.3 Sonidegib (Odomzo)
20.4 Vismodegib (Erivedge)
20.5 Imiquimod (Aldara/Zyclara)
20.6 Amivolevulinic Acid (Ameluz)
20.7 Methyl Aminolevulinate (Metvixia/Metvix PDT)
20.8 Vemurafenib (Zelboraf)
21. Small Molecule Drugs for Pancreatic Cancer – Availability, Dosage and Price Analysis
21.1 Irinotecan Liposome Injection (Onivyde)
22. Small Molecule Drugs for Thyroid Tumors – Availability, Dosage and Price Analysis
22.1 Vendetanib (Caprelsa)
23. Small Molecule Drugs for Renal Cancer – Availability, Dosage and Price Analysis
23.1 Axitinib (Inlyta)
24. Small Molecule Drugs for Colorectum Cancer – Availability, Dosage and Price Analysis
24.1 Tipiracil/Trifluridine (Lonsurf)
24.2 Irinotecan (Camptosar)
24.3 Oxaliplatin (Eloxatin)
24.4 Raltitrexed (Tomudex)
24.5 Irinotecan-Eluting Beads (Paragon Beads/Debiri)
24.6 Fruquintinib (Elunate)
25. Small Molecule Drugs for Solid Tumors – Availability, Dosage and Price Analysis
25.1 Larotectinib (Viktravi)
26. Small Molecule Drugs Targeting Multiple Cancer – Availability, Dosage, Price and Sales Analysis
26.1 Fludarabin (Fludara/Oforta)
26.2 Gemcitabine (Gemzar)
26.3 Sorafnib (Nexavar)
26.4 Rucaparib (Rubraca)
26.5 Doxorubicin (Aridamycin)
26.6 Acalabrutinib (Calquence)
26.7 Ibrutinib (Imbruvica)
26.8 Azacitidine (Vidaza)
26.9 Lenalidomide (Revlimid)
26.10 Doxorubicin Liposomal (Doxil)
26.11 Tazemetostat (Tazverik)
26.12 Busulfan (Busulfex)
26.13 Afatinib (Gilotrif)
26.14 Gemcitabine (Infugem)
26.15 Carmustine Polifeprosan 20 wafer (Gliadel)
26.16 Eribulin (Halaven)
26.17 Paclitaxel-Protein Bound (Abraxane)
26.18 Trabectedine (Yondelis)
26.19 Paclitaxel (Taxol)
26.20 Docetaxel (Taxotere)
26.21 Idelalisib (Zydelig)
26.22 Duvelisib (Copiktra)
26.23 Regorafenib (Stivagra)
26.24 Nelarabine (Arranon)
26.25 Capecitabine (Xeloda)
26.26 Lenvatinib (Lenvima)
26.27 Olaparib (Lynparza)
26.28 Niraparib (Zejula)
26.29 Pazopanib (Votrient)
26.30 Alitretinoin Topical (Panretin)
26.31 Mitotane (Lysodren)
26.32 Valrubicin (Valstar)
26.33 Hydroxyurea (Hydrea)
26.34 Mitoxantrone (Novantrone)
26.35 Zoledronic Acid (Zometa/Reclast)
26.36 Fotemustine (Muforan)
26.37 Paclitaxel Nanoparticle (Nanoxel)
26.38 Topotecan (Hycamtin)
26.39 Decitabine (Decogen)
26.40 Tivozanib (Fotivda)
26.41 Telotristat Etiprate (Xermelo)
26.42 Imatinib (Gleevec)
26.43 Trametinib (Mekinist)
26.44 Cabozantinib (Cabometyx)
26.45 Encorafenib (Braftovi)
26.46 Dabrafenib (Tafinlar)
26.47 Sunintab (Sutent)
26.48 Levoleucovorin (Fusilev/Khapzory)
26.49 Bendamustine (Treanda/Belrapzo/Bendeka)
26.50 Forodesine (Fodosine/Mundesine)
26.51 Talaporfin (Laserphyrin)
26.52 Tucidinostat (Epidaza)
26.53 Doxorubicin Eluting Beads (DC Beads)
26.54 Temozolomide (Temodar)
26.55 Paclitaxel Polymeric Micelle Formulation (GenexolPM)
26.56 Docetaxel polymeric micelle (Nanoxel M)
26.57 Methotrexate
26.58 Treosulfan (Ovastat/Tercondi)
26.59 Belotecan (Camtobell)
26.60 Paclitaxel Liposomal(Lipusu/Bevetex)
26.61 Amsacrine (Amsa PD/Amekrin)
26.62 Cyclophosphamide
26.63 Docetaxel Nanosome (DoceAqualip)
26.64 Pamidronic acid (Aredia)
26.65 Mopidamol (Rapenton)
26.66 Nedaplatin (Aqupla)
26.67 Cytarabin/Cytarabin Liposomal (DepoCyt)
26.68 Dianhydrogalactitol (DAG for Injection)
27. Competitive Landscape
27.1 Johnson and Johnson
27.2 Teva Pharmaceutical
27.3 Boehringer Ingelheim
27.4 Allergan
27.5 Pfizer
27.6 Bristol-Myers Squibb
27.7 Merck
27.8 GlaxoSmithKline
27.9 AstraZeneca
27.10 Gilead Sciences
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer